IP Library Granted Patent US 9,861,609
Granted Patent B2
US 9,861,609 · App. 15/242,189 · Granted Jan 9, 2018

Chemical engineering processes and apparatus for the synthesis of compounds

Inventors: Robert Winnicki (Cambridge, MA); Marc Donsky (Denver, CO); Mingyang Sun (Dublin, IE); Richard Peet (Washington, DC)
Assignee: FULL SPECTRUM LABORATORIES LIMITED
A61K31/352C12M21/18C12M41/30C12M41/48C12P7/42C12P17/06C12Y121/03007C12Y121/03008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,861,609
App. No.
15/242,189
Granted
Jan 9, 2018
Kind
B2
Abstract

The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase. Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.

Claims (22)

1. A system for producing cannabinoid products, comprising:

a fermentor holding a cell culture medium comprising genetically engineered yeast or bacterial cells producing and secreting a cannabinoid synthase which is tetrahydrocannabinolic acid (THCA) or cannabidiolic acid (CBDA) synthase into the medium;

a bioreactor containing a reaction mixture configured to interact the cannabinoid synthases with a compound of formula I to form one or more cannabinoid products which are synthesized by said synthases

wherein said formula I has the following chemical structure:

wherein

R is —OH:

R 1 is —H or —COOH;

R 2 is a C 1 -C 10 linear or branched alkyl wherein said C 1 -C 10 linear alkyl is selected from the group consisting of CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 6 H 13 , C 7 H 15 , C 8 H 17 , iso-propyl, sec-butyl, iso-butyl, neopentyl, 2-methyl hexyl, and 2,3-dimethyl hexyl;

R 3 is H; and

a control mechanism configured to regulate a property of the medium containing the cannabinoid synthase or to control a property of the reaction mixture to modify the amount of the one or more cannabinoid products; wherein the property of the reaction mixture is one or more of the ionic strength of the reaction, the pH of the reaction, the temperature of the reaction, or the pressure of the reaction, wherein the pH of said reaction mixture is from 4 to less than 8.

2. The system of claim 1 , further comprising a filter configured to separate the cells from the medium containing the cannabinoid synthase produced by the cells.

3. The system of claim 1 , wherein the control mechanism comprises a processing circuit and a display to control one or more properties of the reaction mixture.

4. The system of claim 1 , wherein the property of the medium containing the cannabinoid synthase is on or more of the oxygen level of the medium, the rate of agitation of the medium, the pH of the medium, or the flow rate of the medium into the bioreactor.

5. The system of claim 1 , wherein the bioreactor is a column bioreactor containing nickel, and wherein the cannabinoid synthase includes a tag configured to bond to nickel.

6. The system of claim 1 , wherein the bacterial cells are Escherichia coli cells.

7. The system of claim 1 , wherein the reaction mixture comprises a reagent and a solvent.

8. The system of claim 7 , wherein the solvent is one or more of dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), iso-propoyl alcohol and cyclodextrin.

9. The system of claim 8 , wherein the concentration of the solvent in the reaction mixture is between 5% and 30% (w/v).

10. The system of claim 1 , wherein the cells are genetically modified to produce and secrete tetrahydrocannabinolic acid synthase (THCA synthase).

11. The system of claim 1 , wherein the cells are genetically modified to produce and secrete cannabidiolic acid synthase (CBDA synthase).

12. The system of claim 1 , to in the compound of formula I, R 2 is selected from the group consisting of CH 3 , C 2 H 5 , C 3 H 7 , C 4 H 9 , C 6 H 13 , C 7 H 15 , C 8 H 17 .

13. The system of claim 1 , wherein in the compound of formula I, R 2 is C 3 H 7 .

Assignments (7)
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0448 →
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0474 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058180/0377 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058182/0033 →
SECURITY INTEREST Recorded Aug 24, 2020
From: TEEWINOT TECHNOLOGIES, LTD.
To: TUATARA CAPITAL FUND I, L.P.
Reel/Frame 053582/0897 →
CHANGE OF NAME Recorded Dec 8, 2017
From: FULL SPECTRUM LABORATORIES LIMITED
To: TEEWINOT TECHNOLOGIES LIMITED
Reel/Frame 044804/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2017
From: SUN, MINGYANG; PEET, RICHARD
To: FULL SPECTRUM LABORATORIES LIMITED
Reel/Frame 043374/0835 →
Continuity (5)
Continuation 15171517 · Jun 2, 2016
Continuation 14836339 · Aug 26, 2015
Continuation PCTUS2014018944 · Feb 27, 2014
Provisional Application 61770766 · Feb 28, 2013
Related Publication 20160355854A1 · Dec 8, 2016